Mapping the Global Research and Clinical Trials in COVID-19
Aggarwal, R.; Bhattacharya, S.; Singh, S.
Show abstract
COVID-19 has created an unprecedented level of research and innovation activity globally to bring out drug to control or cure the disease, and develop vaccine for long time prevention. A new/better normal is emerging that is trying to push this time period for drug development and vaccine within a year and earlier than that from typical 8 to 10 years for drugs and 10 to 15 years for vaccine. This is happening due to multiple factors: strong policy push by different government that includes dedicated investment, speeding up regulation process, multiple agencies involvement, and multilateral bodies led by WHO trying to create a global platform, huge grants from private funding bodies, strategic linkages across the whole research and innovation value chain between firms, academic, research organisations and start-ups. The paper maps the research papers and ongoing clinical trials to provide an informed view of the current status of the research and drug development activity as seen through the lens of research papers and clinical trials. The intended goal of this study is to help the research community and policy makers to keep track of highly relevant research and drug development in COVID-19.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identification, analysis and prediction of valid and false information related to vaccines from Romanian tweets 91%
- The impact of armed conflict on the epidemiological situation of Coronavirus disease (COVID-19) in Libya, Syria, and Yemen 90%
- Nowcasting and Forecasting the Spread of COVID-19 and Healthcare Demand In Turkey, A Modelling Study 90%
Similar papers in this journal
- Mapping the coevolution, leadership and financing of research on viral vectors, RNAi, CRSPR/Cas9 and other genomic editing technologies 93%
- Acceptance and Attitudes Toward COVID-19 Vaccines: A Cross-Sectional Study from Jordan 91%
- Modelling the impact of behavioural interventions during pandemics: A systematic review 91%
Similar papers in this journal
- Growth rate and acceleration analysis of the COVID-19 pandemic reveals the effect of public health measures in real time 91%
- Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared with Hunan, China 89%
- Effect of a one-month lockdown on the epidemic dynamics of COVID-19 in France 88%
Similar papers in this journal
- Machine learning prediction of antiviral-HPV protein interactions for anti-HPV pharmacotherapy 91%
- Identification of multi-targeting and synergistic neuromodulators of epilepsy associated protein-targets in Ayurvedic herbs using network pharmacological approach 90%
- Digitalization impacts the COVID-19 pandemic and the stringency of government measures 89%
Similar papers in this journal
- The impact of National Centralized Drug Procurement policy on the use of policy-related original and generic drugs in public medical institutions in China: A difference-in-difference analysis based on national database 91%
- Online Queries As A Criterion For Evaluation Of The Epidemiological Status And Effectiveness Of COVID-19 Epidemic Control Measures 91%
- Incidences of poor-quality pharmaceutical products in Nepal 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.